Skip to main content
Erschienen in: Archives of Dermatological Research 2/2012

01.03.2012 | News & Views

Exploring the role of prolactin in psoriasis

verfasst von: Ewan A. Langan, Christopher E. M. Griffiths, Ralf Paus

Erschienen in: Archives of Dermatological Research | Ausgabe 2/2012

Einloggen, um Zugang zu erhalten

Abstract

Prolactin (PRL) is well recognised for its role(s) in mammary gland development and function. Moreover, its role in skin biology, including the potent regulation of human hair growth, is becoming clearer. Less widely appreciated, however, is the potential role of PRL in the pathobiology of psoriasis. While the relationship between PRL and psoriasis remains enigmatic, several recent publications on the PRL–psoriasis connection have demonstrated a reawakening of interest in this conundrum. We take the occasion of these reports to underscore the importance of dissecting the role(s) of PRL in the aetiopathology of psoriasis, not least since this may help to identify novel hormonal treatment strategies in its management.
Literatur
1.
Zurück zum Zitat Al’Abadie MS, Kent GG, Gawkrodger DJ (1994) The relationship between stress and the onset and exacerbation of psoriasis and other skin conditions. Br J Dermatol 130(2):199–203PubMedCrossRef Al’Abadie MS, Kent GG, Gawkrodger DJ (1994) The relationship between stress and the onset and exacerbation of psoriasis and other skin conditions. Br J Dermatol 130(2):199–203PubMedCrossRef
2.
Zurück zum Zitat Angioni AR, Lania A, Cattaneo A, Beck-Peccoz P, Spada A (2005) Effects of chronic retinoid administration on pituitary function. J Endocrinol Invest 28(11):961–964PubMed Angioni AR, Lania A, Cattaneo A, Beck-Peccoz P, Spada A (2005) Effects of chronic retinoid administration on pituitary function. J Endocrinol Invest 28(11):961–964PubMed
3.
Zurück zum Zitat Arnetz BB, Fjellner B, Eneroth P, Kallner A (1985) Stress and psoriasis: psychoendocrine and metabolic reactions in psoriatic patients during standardized stressor exposure. Psychosom Med 47(6):528–541PubMed Arnetz BB, Fjellner B, Eneroth P, Kallner A (1985) Stress and psoriasis: psychoendocrine and metabolic reactions in psoriatic patients during standardized stressor exposure. Psychosom Med 47(6):528–541PubMed
4.
Zurück zum Zitat Ben-Jonathan N, Mershon JL, Allen DL, Steinmetz RW (1996) Extrapituitary prolactin: distribution, regulation, functions, and clinical aspects. Endocr Rev 17(6):639–669PubMed Ben-Jonathan N, Mershon JL, Allen DL, Steinmetz RW (1996) Extrapituitary prolactin: distribution, regulation, functions, and clinical aspects. Endocr Rev 17(6):639–669PubMed
5.
Zurück zum Zitat Bernton E, Bryant H, Holaday J, Dave J (1992) Prolactin and prolactin secretagogues reverse immunosuppression in mice treated with cysteamine, glucocorticoids, or cyclosporin-A. Brain Behav Immun 6(4):394–408PubMedCrossRef Bernton E, Bryant H, Holaday J, Dave J (1992) Prolactin and prolactin secretagogues reverse immunosuppression in mice treated with cysteamine, glucocorticoids, or cyclosporin-A. Brain Behav Immun 6(4):394–408PubMedCrossRef
6.
Zurück zum Zitat Biswas R, Roy T, Chattopadhyay U (2006) Prolactin induced reversal of glucocorticoid mediated apoptosis of immature cortical thymocytes is abrogated by induction of tumor. J Neuroimmunol 171(1–2):120–134PubMedCrossRef Biswas R, Roy T, Chattopadhyay U (2006) Prolactin induced reversal of glucocorticoid mediated apoptosis of immature cortical thymocytes is abrogated by induction of tumor. J Neuroimmunol 171(1–2):120–134PubMedCrossRef
7.
Zurück zum Zitat Chikanza IC (1999) Prolactin and neuroimmunomodulation: in vitro and in vivo observations. Ann N Y Acad Sci 876:119–130PubMedCrossRef Chikanza IC (1999) Prolactin and neuroimmunomodulation: in vitro and in vivo observations. Ann N Y Acad Sci 876:119–130PubMedCrossRef
8.
Zurück zum Zitat De Bellis A, Bizzarro A, Pivonello R, Lombardi G, Bellastella A (2005) Prolactin and autoimmunity. Pituitary 8(1):25–30PubMedCrossRef De Bellis A, Bizzarro A, Pivonello R, Lombardi G, Bellastella A (2005) Prolactin and autoimmunity. Pituitary 8(1):25–30PubMedCrossRef
9.
Zurück zum Zitat Dilme-Carreras E, Martin-Ezquerra G, Sanchez-Regana M, Umbert-Millet P (2011) Serum prolactin levels in psoriasis and correlation with cutaneous disease activity. Clin Exp Dermatol 36(1):29–32PubMedCrossRef Dilme-Carreras E, Martin-Ezquerra G, Sanchez-Regana M, Umbert-Millet P (2011) Serum prolactin levels in psoriasis and correlation with cutaneous disease activity. Clin Exp Dermatol 36(1):29–32PubMedCrossRef
10.
Zurück zum Zitat El-Khateeb EA, Zuel-Fakkar NM, Eid SM, Abdul-Wahab SE (2011) Prolactin level is significantly elevated in lesional skin of patients with psoriasis. Int J Dermatol 50(6):693–696PubMedCrossRef El-Khateeb EA, Zuel-Fakkar NM, Eid SM, Abdul-Wahab SE (2011) Prolactin level is significantly elevated in lesional skin of patients with psoriasis. Int J Dermatol 50(6):693–696PubMedCrossRef
11.
Zurück zum Zitat Evers AW, Verhoeven EW, Kraaimaat FW, De Jong EM, De Brouwer SJ, Schalkwijk J, Sweep FC, Van De Kerkhof PC (2010) How stress gets under the skin: cortisol and stress reactivity in psoriasis. Br J Dermatol 163(5):986–991PubMedCrossRef Evers AW, Verhoeven EW, Kraaimaat FW, De Jong EM, De Brouwer SJ, Schalkwijk J, Sweep FC, Van De Kerkhof PC (2010) How stress gets under the skin: cortisol and stress reactivity in psoriasis. Br J Dermatol 163(5):986–991PubMedCrossRef
12.
Zurück zum Zitat Fitch E, Harper E, Skorcheva I, Kurtz SE, Blauvelt A (2007) Pathophysiology of psoriasis: recent advances on IL-23 and Th17 cytokines. Curr Rheumatol Rep 9(6):461–467PubMedCrossRef Fitch E, Harper E, Skorcheva I, Kurtz SE, Blauvelt A (2007) Pathophysiology of psoriasis: recent advances on IL-23 and Th17 cytokines. Curr Rheumatol Rep 9(6):461–467PubMedCrossRef
13.
Zurück zum Zitat Foitzik K, Krause K, Conrad F, Nakamura M, Funk W, Paus R (2006) Human scalp hair follicles are both a target and a source of prolactin, which serves as an autocrine and/or paracrine promoter of apoptosis-driven hair follicle regression. Am J Pathol 168(3):748–756PubMedCrossRef Foitzik K, Krause K, Conrad F, Nakamura M, Funk W, Paus R (2006) Human scalp hair follicles are both a target and a source of prolactin, which serves as an autocrine and/or paracrine promoter of apoptosis-driven hair follicle regression. Am J Pathol 168(3):748–756PubMedCrossRef
14.
Zurück zum Zitat Fomicheva EE, Nemirovich-Danchenko EA, Korneva EA (2004) Immunoprotective effects of prolactin during stress-induced immune dysfunction. Bull Exp Biol Med 137(6):544–547PubMedCrossRef Fomicheva EE, Nemirovich-Danchenko EA, Korneva EA (2004) Immunoprotective effects of prolactin during stress-induced immune dysfunction. Bull Exp Biol Med 137(6):544–547PubMedCrossRef
15.
Zurück zum Zitat Fortune DG, Richards HL, Kirby B, McElhone K, Markham T, Rogers S, Main CJ, Griffiths CE (2003) Psychological distress impairs clearance of psoriasis in patients treated with photochemotherapy. Arch Dermatol 139(6):752–756PubMedCrossRef Fortune DG, Richards HL, Kirby B, McElhone K, Markham T, Rogers S, Main CJ, Griffiths CE (2003) Psychological distress impairs clearance of psoriasis in patients treated with photochemotherapy. Arch Dermatol 139(6):752–756PubMedCrossRef
16.
Zurück zum Zitat Freeman ME, Kanyicska B, Lerant A, Nagy G (2000) Prolactin: structure, function, and regulation of secretion. Physiol Rev 80(4):1523–1631PubMed Freeman ME, Kanyicska B, Lerant A, Nagy G (2000) Prolactin: structure, function, and regulation of secretion. Physiol Rev 80(4):1523–1631PubMed
17.
Zurück zum Zitat Giasuddin AS, El-Sherif AI, El-Ojali SI (1998) Prolactin: does it have a role in the pathogenesis of psoriasis? Dermatology 197(2):119–122PubMedCrossRef Giasuddin AS, El-Sherif AI, El-Ojali SI (1998) Prolactin: does it have a role in the pathogenesis of psoriasis? Dermatology 197(2):119–122PubMedCrossRef
18.
Zurück zum Zitat Goffin V, Binart N, Touraine P, Kelly PA (2002) Prolactin: the new biology of an old hormone. Annu Rev Physiol 64:47–67PubMedCrossRef Goffin V, Binart N, Touraine P, Kelly PA (2002) Prolactin: the new biology of an old hormone. Annu Rev Physiol 64:47–67PubMedCrossRef
19.
Zurück zum Zitat Guilhou JJ, Guilhou E (1982) Bromocriptine treatment of psoriasis. Arch Dermatol Res 273(1–2):159–160PubMedCrossRef Guilhou JJ, Guilhou E (1982) Bromocriptine treatment of psoriasis. Arch Dermatol Res 273(1–2):159–160PubMedCrossRef
20.
Zurück zum Zitat Holt RI (2008) Medical causes and consequences of hyperprolactinaemia. A context for psychiatrists. J Psychopharmacol 22(2 Suppl):28–37PubMedCrossRef Holt RI (2008) Medical causes and consequences of hyperprolactinaemia. A context for psychiatrists. J Psychopharmacol 22(2 Suppl):28–37PubMedCrossRef
21.
Zurück zum Zitat Kanda N, Shibata S, Tada Y, Nashiro K, Tamaki K, Watanabe S (2009) Prolactin enhances basal and IL-17-induced CCL20 production by human keratinocytes. Eur J Immunol 39(4):996–1006PubMedCrossRef Kanda N, Shibata S, Tada Y, Nashiro K, Tamaki K, Watanabe S (2009) Prolactin enhances basal and IL-17-induced CCL20 production by human keratinocytes. Eur J Immunol 39(4):996–1006PubMedCrossRef
22.
Zurück zum Zitat Kanda N, Watanabe S (2007) Prolactin enhances interferon-gamma-induced production of CXC ligand 9 (CXCL9), CXCL10, and CXCL11 in human keratinocytes. Endocrinology 148(5):2317–2325PubMedCrossRef Kanda N, Watanabe S (2007) Prolactin enhances interferon-gamma-induced production of CXC ligand 9 (CXCL9), CXCL10, and CXCL11 in human keratinocytes. Endocrinology 148(5):2317–2325PubMedCrossRef
23.
Zurück zum Zitat Kimball AB, Szapary P, Mrowietz U, Reich K, Langley RG, You Y, Hsu MC, Yeilding N, Rader DJ, Mehta NN (2011) Underdiagnosis and undertreatment of cardiovascular risk factors in patients with moderate to severe psoriasis. J Am Acad Dermatol. doi:10.1016/j.jaad.2011.06.035 Kimball AB, Szapary P, Mrowietz U, Reich K, Langley RG, You Y, Hsu MC, Yeilding N, Rader DJ, Mehta NN (2011) Underdiagnosis and undertreatment of cardiovascular risk factors in patients with moderate to severe psoriasis. J Am Acad Dermatol. doi:10.​1016/​j.​jaad.​2011.​06.​035
24.
Zurück zum Zitat Komossa K, Rummel-Kluge C, Hunger H, Schmid F, Schwarz S, Duggan L, Kissling W, Leucht S (2010) Olanzapine versus other atypical antipsychotics for schizophrenia. Cochrane Database Syst Rev (3):CD006654. doi:10.1002/14651858 Komossa K, Rummel-Kluge C, Hunger H, Schmid F, Schwarz S, Duggan L, Kissling W, Leucht S (2010) Olanzapine versus other atypical antipsychotics for schizophrenia. Cochrane Database Syst Rev (3):CD006654. doi:10.​1002/​14651858
25.
Zurück zum Zitat Kotrulja L, Tadinac M, Joki-Begi NA, Gregurek R (2010) A multivariate analysis of clinical severity, psychological distress and psychopathological traits in psoriatic patients. Acta Derm Venereol 90(3):251–256PubMed Kotrulja L, Tadinac M, Joki-Begi NA, Gregurek R (2010) A multivariate analysis of clinical severity, psychological distress and psychopathological traits in psoriatic patients. Acta Derm Venereol 90(3):251–256PubMed
26.
Zurück zum Zitat Langan EA, Foitzik-Lau K, Goffin V, Ramot Y, Paus R (2010) Prolactin: an emerging force along the cutaneous-endocrine axis. Trends Endocrinol Metab 21(9):569–577PubMedCrossRef Langan EA, Foitzik-Lau K, Goffin V, Ramot Y, Paus R (2010) Prolactin: an emerging force along the cutaneous-endocrine axis. Trends Endocrinol Metab 21(9):569–577PubMedCrossRef
27.
Zurück zum Zitat Langan EA, Ramot Y, Goffin V, Griffiths CE, Foitzik K, Paus R (2010) Mind the (gender) gap: does prolactin exert gender and/or site-specific effects on the human hair follicle? J Invest Dermatol 130(3):886–891PubMedCrossRef Langan EA, Ramot Y, Goffin V, Griffiths CE, Foitzik K, Paus R (2010) Mind the (gender) gap: does prolactin exert gender and/or site-specific effects on the human hair follicle? J Invest Dermatol 130(3):886–891PubMedCrossRef
28.
Zurück zum Zitat Langan EA, Ramot Y, Hanning A, Poeggeler B, Biro T, Gaspar E, Funk W, Griffiths CE, Paus R (2010) Thyrotropin-releasing hormone and oestrogen differentially regulate prolactin and prolactin receptor expression in female human skin and hair follicles in vitro. Br J Dermatol 162(5):1127–1131PubMedCrossRef Langan EA, Ramot Y, Hanning A, Poeggeler B, Biro T, Gaspar E, Funk W, Griffiths CE, Paus R (2010) Thyrotropin-releasing hormone and oestrogen differentially regulate prolactin and prolactin receptor expression in female human skin and hair follicles in vitro. Br J Dermatol 162(5):1127–1131PubMedCrossRef
29.
Zurück zum Zitat Lennartsson AK, Jonsdottir IH (2011) Prolactin in response to acute psychosocial stress in healthy men and women. Psychoneuroendocrinology 36(10):1530–1539PubMedCrossRef Lennartsson AK, Jonsdottir IH (2011) Prolactin in response to acute psychosocial stress in healthy men and women. Psychoneuroendocrinology 36(10):1530–1539PubMedCrossRef
30.
Zurück zum Zitat Lu Z, Hasse S, Bodo E, Rose C, Funk W, Paus R (2007) Towards the development of a simplified long-term organ culture method for human scalp skin and its appendages under serum-free conditions. Exp Dermatol 16(1):37–44PubMedCrossRef Lu Z, Hasse S, Bodo E, Rose C, Funk W, Paus R (2007) Towards the development of a simplified long-term organ culture method for human scalp skin and its appendages under serum-free conditions. Exp Dermatol 16(1):37–44PubMedCrossRef
31.
Zurück zum Zitat Mackin P, Waton A, Nulkar A, Watkinson HM (2011) Prolactin and smoking status in antipsychotic-treated patients. J Psychopharmacol 25 (5):698–703 Mackin P, Waton A, Nulkar A, Watkinson HM (2011) Prolactin and smoking status in antipsychotic-treated patients. J Psychopharmacol 25 (5):698–703
32.
Zurück zum Zitat Malligarjunan H, Gnanaraj P, Subramanian S, Elango T, Dayalan H (2011) Clinical efficacy of propylthiouracil and its influence on prolactin in psoriatic patients. Clin Biochem 44(14–15):1209–1213PubMedCrossRef Malligarjunan H, Gnanaraj P, Subramanian S, Elango T, Dayalan H (2011) Clinical efficacy of propylthiouracil and its influence on prolactin in psoriatic patients. Clin Biochem 44(14–15):1209–1213PubMedCrossRef
33.
Zurück zum Zitat Mukherjee A, Helbert M, Ryder WD, Borrow R, Davis JR, Shalet SM (2009) Failure of antibody response to polysaccharide antigen in treated panhypopituitary adults. Clin Exp Immunol 156(2):271–277PubMedCrossRef Mukherjee A, Helbert M, Ryder WD, Borrow R, Davis JR, Shalet SM (2009) Failure of antibody response to polysaccharide antigen in treated panhypopituitary adults. Clin Exp Immunol 156(2):271–277PubMedCrossRef
34.
Zurück zum Zitat Nagy E, Berczi I (1991) Hypophysectomized rats depend on residual prolactin for survival. Endocrinology 128(6):2776–2784PubMedCrossRef Nagy E, Berczi I (1991) Hypophysectomized rats depend on residual prolactin for survival. Endocrinology 128(6):2776–2784PubMedCrossRef
35.
Zurück zum Zitat Paus R (1991) Does prolactin play a role in skin biology and pathology? Med Hypotheses 36(1):33–42PubMedCrossRef Paus R (1991) Does prolactin play a role in skin biology and pathology? Med Hypotheses 36(1):33–42PubMedCrossRef
36.
Zurück zum Zitat Pellegrini I, Lebrun JJ, Ali S, Kelly PA (1992) Expression of prolactin and its receptor in human lymphoid cells. Mol Endocrinol 6(7):1023–1031PubMedCrossRef Pellegrini I, Lebrun JJ, Ali S, Kelly PA (1992) Expression of prolactin and its receptor in human lymphoid cells. Mol Endocrinol 6(7):1023–1031PubMedCrossRef
37.
Zurück zum Zitat Ramot Y, Biro T, Tiede S, Toth BI, Langan EA, Sugawara K, Foitzik K, Ingber A, Goffin V, Langbein L, Paus R (2010) Prolactin—a novel neuroendocrine regulator of human keratin expression in situ. Faseb J 24(6):1768–1779PubMedCrossRef Ramot Y, Biro T, Tiede S, Toth BI, Langan EA, Sugawara K, Foitzik K, Ingber A, Goffin V, Langbein L, Paus R (2010) Prolactin—a novel neuroendocrine regulator of human keratin expression in situ. Faseb J 24(6):1768–1779PubMedCrossRef
38.
Zurück zum Zitat Richards HL, Ray DW, Kirby B, Mason D, Plant D, Main CJ, Fortune DG, Griffiths CE (2005) Response of the hypothalamic-pituitary-adrenal axis to psychological stress in patients with psoriasis. Br J Dermatol 153(6):1114–1120PubMedCrossRef Richards HL, Ray DW, Kirby B, Mason D, Plant D, Main CJ, Fortune DG, Griffiths CE (2005) Response of the hypothalamic-pituitary-adrenal axis to psychological stress in patients with psoriasis. Br J Dermatol 153(6):1114–1120PubMedCrossRef
39.
Zurück zum Zitat Slominski A, Malarkey WB, Wortsman J, Asa SL, Carlson A (2000) Human skin expresses growth hormone but not the prolactin gene. J Lab Clin Med 136(6):476–481PubMedCrossRef Slominski A, Malarkey WB, Wortsman J, Asa SL, Carlson A (2000) Human skin expresses growth hormone but not the prolactin gene. J Lab Clin Med 136(6):476–481PubMedCrossRef
40.
Zurück zum Zitat Sobrinho LG (2003) Prolactin, psychological stress and environment in humans: adaptation and maladaptation. Pituitary 6(1):35–39PubMedCrossRef Sobrinho LG (2003) Prolactin, psychological stress and environment in humans: adaptation and maladaptation. Pituitary 6(1):35–39PubMedCrossRef
41.
Zurück zum Zitat Stevens A, Ray DW, Worthington J, Davis JR (2001) Polymorphisms of the human prolactin gene—implications for production of lymphocyte prolactin and systemic lupus erythematosus. Lupus 10(10):676–683PubMedCrossRef Stevens A, Ray DW, Worthington J, Davis JR (2001) Polymorphisms of the human prolactin gene—implications for production of lymphocyte prolactin and systemic lupus erythematosus. Lupus 10(10):676–683PubMedCrossRef
42.
Zurück zum Zitat Tomei F, Ciarrocca M, Cherubini E, Rosati MV, Monti C, Capozzella A, Tomei G (2006) Prolactin levels in workers exposed to chemical, physical and psycho-social urban stressors. J Occup Health 48(4):253–260PubMedCrossRef Tomei F, Ciarrocca M, Cherubini E, Rosati MV, Monti C, Capozzella A, Tomei G (2006) Prolactin levels in workers exposed to chemical, physical and psycho-social urban stressors. J Occup Health 48(4):253–260PubMedCrossRef
43.
Zurück zum Zitat Walker AM, Robertson MT, Jones CJ (1989) Distribution of a prolactin-like material in human eccrine sweat glands. J Invest Dermatol 93(1):50–53PubMedCrossRef Walker AM, Robertson MT, Jones CJ (1989) Distribution of a prolactin-like material in human eccrine sweat glands. J Invest Dermatol 93(1):50–53PubMedCrossRef
44.
Zurück zum Zitat Weber G, Frey H (1986) Treatment of psoriasis arthropathica with bromocriptine. Z Hautkr 61(20):1456–1466PubMed Weber G, Frey H (1986) Treatment of psoriasis arthropathica with bromocriptine. Z Hautkr 61(20):1456–1466PubMed
45.
Zurück zum Zitat Weber G, Neidhardt M, Frey H, Galle K, Geiger A (1981) Treatment of psoriasis with bromocriptin. Arch Dermatol Res 271(4):437–439PubMedCrossRef Weber G, Neidhardt M, Frey H, Galle K, Geiger A (1981) Treatment of psoriasis with bromocriptin. Arch Dermatol Res 271(4):437–439PubMedCrossRef
46.
Zurück zum Zitat Webster Marketon JI, Glaser R (2008) Stress hormones and immune function. Cell Immunol 252(1–2):16–26PubMedCrossRef Webster Marketon JI, Glaser R (2008) Stress hormones and immune function. Cell Immunol 252(1–2):16–26PubMedCrossRef
47.
Zurück zum Zitat Zouboulis CC (2004) The human skin as a hormone target and an endocrine gland. Hormones (Athens) 3(1):9–26 Zouboulis CC (2004) The human skin as a hormone target and an endocrine gland. Hormones (Athens) 3(1):9–26
Metadaten
Titel
Exploring the role of prolactin in psoriasis
verfasst von
Ewan A. Langan
Christopher E. M. Griffiths
Ralf Paus
Publikationsdatum
01.03.2012
Verlag
Springer-Verlag
Erschienen in
Archives of Dermatological Research / Ausgabe 2/2012
Print ISSN: 0340-3696
Elektronische ISSN: 1432-069X
DOI
https://doi.org/10.1007/s00403-012-1208-6

Weitere Artikel der Ausgabe 2/2012

Archives of Dermatological Research 2/2012 Zur Ausgabe

Leitlinien kompakt für die Dermatologie

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Update Dermatologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.